ADRB2 signaling inhibited sorafenib-induced autophagy, thereby contributing to sorafenib resistance, and ADRB2 inhibitor ICI118551 promoted sorafenib-induced autophagy and inhibition of colony formation by HCC cells in vitro [106]. The gene discussed is ADRB2; the disease is hepatocellular carcinoma.